News

Shares of WW International (NASDAQ: WW), formerly Weight Watchers International, tumbled 11.4% through 1:10 p.m. ET on Thursday at the same time as Eli Lilly (NYSE: LLY) stock resumed its relentless march back toward its 52 week high.

These two events are not unrelated.

Zepbound vs. WeightWatchers

Lilly stock has been buoyed in recent days by the enthusiasm for the company's new Zepbound weight loss drug, which competes with Novo Nordisk's Wegovy and Ozempic, and threatens WW's business model of facilitating long-term weight loss over time, by offering consumers the attractive prospect of weight loss by injection. This morning, Lilly gave WW International investors a new threat to watch out for, announcing its LillyDirect e-commerce platform, permitting patients to get prescriptions via telehealth appointments, and then order "direct home delivery of select Lilly medicines through third-party pharmacy dispensing services."

Is WW International stock a sell?

So you can imagine why that might make investors just the teensiest bit nervous.

Moreover, the company is not in a particularly good position to fight off this threat. Unprofitable in 2022 and 2023, and expected to keep losing money into 2024, WW International remains loaded with debt -- about $1.4 billion net of cash on hand, which is more than twice the company's current market capitalization.

Analysts still think the company can turn things around and resume generating profits in 2025. But when you consider that WW's revenue has been shrinking for five straight years -- and that this was already happening before big pharma began inventing whole families of magical weight loss drugs -- I have to admit that things aren't looking great for the company right now.

And those promises of a profit in 2025 could be as hard to keep as sticking to a New Year's resolution to lose weight.

Should you invest $1,000 in WW International right now?

Before you buy stock in WW International, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and WW International wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.

*Stock Advisor returns as of December 18, 2023

Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.